HK Stock MarketDetailed Quotes
00314 SIPAI HEALTH
- 6.240
- +0.260+4.35%
Not Open Jun 28 16:08 CST
4.76BMarket Cap-16864P/E (TTM)
6.270High5.890Low1.09MVolume5.910Open5.980Pre Close6.70MTurnover0.14%Turnover RatioLossP/E (Static)762.52MShares8.98052wk High2.66P/B4.76BFloat Cap4.89052wk Low--Dividend TTM762.52MShs Float44.600Historical High--Dividend LFY6.36%Amplitude4.890Historical Low6.161Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
SIPAI HEALTH Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Mar 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 14.39%4.71B | 29.15%2.44B | 18.58%4.12B | 21.78%1.89B | 28.68%3.47B | --1.55B | 64.67%765.39M | 159.83%2.7B | --464.79M | 680.88%1.04B |
| Operating income | 14.39%4.71B | 29.15%2.44B | 18.58%4.12B | 21.78%1.89B | 28.68%3.47B | 1.55B | 64.67%765.39M | 159.83%2.7B | 464.79M | 680.88%1.04B |
| Cost of sales | -13.62%-4.3B | -29.76%-2.22B | -18.54%-3.78B | -19.50%-1.71B | -26.97%-3.19B | ---1.43B | -58.79%-713.7M | -162.51%-2.51B | ---449.45M | -680.26%-957.21M |
| Operating expenses | -13.62%-4.3B | -29.76%-2.22B | -18.54%-3.78B | -19.50%-1.71B | -26.97%-3.19B | -1.43B | -58.79%-713.7M | -162.51%-2.51B | -449.45M | -680.26%-957.21M |
| Gross profit | 22.93%414.7M | 23.25%218.09M | 19.02%337.35M | 49.34%176.94M | 51.69%283.45M | 118.48M | 236.88%51.69M | 128.42%186.86M | 15.35M | 688.17%81.8M |
| Selling expenses | 12.18%-292.32M | 5.33%-152.05M | -14.20%-332.85M | -15.33%-160.61M | -58.88%-291.46M | ---139.27M | -97.40%-66.1M | -58.10%-183.45M | ---33.49M | -240.21%-116.03M |
| Administrative expenses | 39.52%-347.79M | 30.50%-175.38M | 14.18%-575.01M | 19.01%-252.33M | -85.48%-670.02M | ---311.54M | -87.21%-129.82M | -64.60%-361.24M | ---69.35M | -52.48%-219.46M |
| Research and development expenses | 26.66%-45.95M | 30.40%-23.86M | -5.82%-62.65M | -17.00%-34.29M | -29.43%-59.21M | ---29.31M | -37.13%-13.06M | -84.08%-45.74M | ---9.52M | -36.37%-24.85M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | -1,108.28%-1.42B | ---- | ---117.58M | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | -1,108.28%-1.42B | ---- | ---117.58M | ---- |
| Impairment and provision | -82.31%-9.97M | 63.44%-1.83M | 14.69%-5.47M | -81.60%-5M | -20.18%-6.41M | ---2.76M | 15.36%-1.97M | -188.94%-5.33M | ---2.33M | -100.11%-1.85M |
| -Other impairment is provision | -82.31%-9.97M | 63.44%-1.83M | 14.69%-5.47M | -81.60%-5M | -20.18%-6.41M | ---2.76M | 15.36%-1.97M | -188.94%-5.33M | ---2.33M | -100.11%-1.85M |
| Operating interest expense | 13.66%-3.49M | 6.75%-1.82M | -9.57%-4.04M | -4.10%-1.96M | -4.56%-3.69M | ---1.88M | -4.66%-943K | -22.59%-3.53M | ---901K | -155.96%-2.88M |
| Special items of operating profit | -19.52%39.56M | 181.42%50.16M | 2.52%49.15M | -0.22%17.82M | 65.38%47.95M | --17.86M | 638.93%8.41M | 329.64%28.99M | --1.14M | 194.03%6.75M |
| Operating profit | 58.68%-245.25M | 66.58%-86.7M | 15.14%-593.51M | 25.54%-259.42M | -82.40%-699.39M | -348.4M | -625.73%-1.57B | -38.67%-383.44M | -216.68M | -14.25%-276.51M |
| Share of profits of associates | -224.47%-412K | ---- | 141.61%331K | 123.68%81K | 310.77%137K | ---342K | -3,916.67%-229K | -111.09%-65K | --6K | 641.77%586K |
| Special items of earning before tax | ---- | ---- | 74.57%-775.26M | 96.07%-85.1M | -363.75%-3.05B | ---2.17B | ---- | -105.36%-657.34M | ---- | ---320.09M |
| Earning before tax | 82.05%-245.67M | 74.83%-86.7M | 63.49%-1.37B | 86.31%-344.44M | -260.06%-3.75B | -2.52B | -625.85%-1.57B | -74.63%-1.04B | -216.68M | -146.34%-596.02M |
| Tax | 68.66%-1.04M | 60.61%-609K | -302.67%-3.32M | -4,168.42%-1.55M | 30.03%-825K | --38K | 121.62%32K | -2,211.76%-1.18M | ---148K | ---51K |
| After-tax profit from continuing operations | 82.02%-246.71M | 74.77%-87.31M | 63.41%-1.37B | 86.25%-345.99M | -259.73%-3.75B | -2.52B | -625.34%-1.57B | -74.82%-1.04B | -216.83M | -146.37%-596.07M |
| Earning after tax | 82.02%-246.71M | 74.77%-87.31M | 63.41%-1.37B | 86.25%-345.99M | -259.73%-3.75B | -2.52B | -625.34%-1.57B | -74.82%-1.04B | -216.83M | -146.37%-596.07M |
| Minority profit | 860.15%9.06M | 1,374.71%5.01M | 85.19%-1.19M | 105.07%340K | -1,170.21%-8.05M | ---6.71M | -800.28%-2.54M | 150.95%752K | --362K | -99.46%-1.48M |
| Profit attributable to shareholders | 81.34%-255.77M | 73.34%-92.32M | 63.36%-1.37B | 86.20%-346.33M | -258.70%-3.74B | -2.51B | -622.97%-1.57B | -75.38%-1.04B | -217.19M | -146.51%-594.6M |
| Basic earnings per share | 96.72%-0.4 | 96.00%-0.14 | 67.59%-12.19 | 86.07%-3.5 | -260.59%-37.61 | -25.12 | -623.50%-15.7 | -75.29%-10.43 | -2.17 | -146.89%-5.95 |
| Diluted earnings per share | 96.72%-0.4 | 96.00%-0.14 | 67.59%-12.19 | 86.07%-3.5 | -260.59%-37.61 | -25.12 | -623.50%-15.7 | -75.29%-10.43 | -2.17 | -146.89%-5.95 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg